ALS 0 3 0 3 B-chronic_disease
diagnosed 4 13 4 13 O
as 14 16 14 16 O
probable 17 25 17 25 O
, 25 26 25 26 O
laboratory 27 37 27 37 O
- 37 38 37 38 O
supported 38 47 38 47 O
probable 48 56 48 56 O
or 57 59 57 59 O
definite 60 68 60 68 O
according 69 78 69 78 O
to 79 81 79 81 O
the 82 85 82 85 O
World 86 91 86 91 O
Federation 92 102 92 102 O
of 103 105 103 105 O
Neurology 106 115 106 115 O
El 116 118 116 118 O
Escorial 119 127 119 127 O
revised 128 135 128 135 O
criteria32 136 146 136 146 O
as 147 149 147 149 O
determined 150 160 150 160 O
by 161 163 161 163 O
a 164 165 164 165 O
neurologist 166 177 166 177 O
with 178 182 178 182 O
neuromuscular 183 196 183 196 O
subspecialty 197 209 197 209 O
training 210 218 210 218 O

Age 0 3 219 222 B-age
18 4 6 223 225 B-lower_bound
years 7 12 226 231 I-lower_bound
or 13 15 232 234 O
older 16 21 235 240 O
at 22 24 241 243 O
the 25 28 244 247 O
time 29 33 248 252 O
of 34 36 253 255 O
the 37 40 256 259 O
screening 41 50 260 269 O
visit 51 56 270 275 O

Alanine 0 7 276 283 B-clinical_variable
aminotransferase 8 24 284 300 I-clinical_variable
( 25 26 301 302 I-clinical_variable
ALT 26 29 302 305 I-clinical_variable
) 29 30 305 306 I-clinical_variable
or 31 33 307 309 O
aspartate 34 43 310 319 B-clinical_variable
aminotransferase 44 60 320 336 I-clinical_variable
( 61 62 337 338 I-clinical_variable
AST 62 65 338 341 I-clinical_variable
) 65 66 341 342 I-clinical_variable
greater 67 74 343 350 O
than 75 79 351 355 O
3.0 80 83 356 359 B-lower_bound
times 84 89 360 365 I-lower_bound
the 90 93 366 369 I-lower_bound
upper 94 99 370 375 I-lower_bound
limit 100 105 376 381 I-lower_bound
of 106 108 382 384 I-lower_bound
normal 109 115 385 391 I-lower_bound
for 116 119 392 395 O
the 120 123 396 399 O
NIH 124 127 400 403 O
Clinical 128 136 404 412 O
Center 137 143 413 419 O

Creatine 0 8 420 428 B-clinical_variable
kinase 9 15 429 435 I-clinical_variable
greater 16 23 436 443 O
than 24 28 444 448 O
3.0 29 32 449 452 B-lower_bound
times 33 38 453 458 I-lower_bound
the 39 42 459 462 I-lower_bound
upper 43 48 463 468 I-lower_bound
limit 49 54 469 474 I-lower_bound
of 55 57 475 477 I-lower_bound
normal 58 64 478 484 I-lower_bound
for 65 68 485 488 O
the 69 72 489 492 O
NIH 73 76 493 496 O
Clinical 77 85 497 505 O
Center 86 92 506 512 O

Dementia 0 8 513 521 B-chronic_disease

Dependence 0 10 522 532 O
on 11 13 533 535 O
daytime 14 21 536 543 O
mechanical 22 32 544 554 O
ventilation 33 44 555 566 O
( 45 46 567 568 O
invasive 46 54 568 576 O
or 55 57 577 579 O
non 58 61 580 583 O
- 61 62 583 584 O
invasive 62 70 584 592 O
, 70 71 592 593 O
including 72 81 594 603 O
Continuous 82 92 604 614 B-treatment
Positive 93 101 615 623 I-treatment
Airway 102 108 624 630 I-treatment
Pressure 109 117 631 639 I-treatment
( 118 119 640 641 I-treatment
CPAP 119 123 641 645 I-treatment
) 123 124 645 646 I-treatment
or 125 127 647 649 O
Bilevel 128 135 650 657 B-treatment
Positive 136 144 658 666 I-treatment
Airway 145 151 667 673 I-treatment
Pressure 152 160 674 682 I-treatment
( 161 162 683 684 I-treatment
BiPap 162 167 684 689 I-treatment
) 167 168 689 690 I-treatment
at 169 171 691 693 O
the 172 175 694 697 O
time 176 180 698 702 O
of 181 183 703 705 O
the 184 187 706 709 O
screening 188 197 710 719 O
visit 198 203 720 725 O

Detectable 0 10 726 736 O
HERV 11 15 737 741 B-clinical_variable
- 15 16 741 742 I-clinical_variable
K 16 17 742 743 I-clinical_variable
viral 18 23 744 749 I-clinical_variable
load 24 28 750 754 I-clinical_variable
in 29 31 755 757 O
blood 32 37 758 763 O
at 38 40 764 766 O
a 41 42 767 768 O
minimum 43 50 769 776 O
of 51 53 777 779 O
1000 54 58 780 784 B-lower_bound
copies 59 65 785 791 I-lower_bound
/ 65 66 791 792 I-lower_bound
ml 66 68 792 794 I-lower_bound
as 69 71 795 797 O
measured 72 80 798 806 O
by 81 83 807 809 O
quantitative 84 96 810 822 O
PCR 97 100 823 826 B-treatment
at 101 103 827 829 O
the 104 107 830 833 O
screening 108 117 834 843 O
visit 118 123 844 849 O

Diabetes 0 8 850 858 B-chronic_disease
mellitus 9 17 859 867 I-chronic_disease

Estimated 0 9 868 877 B-clinical_variable
glomerular 10 20 878 888 I-clinical_variable
filtration 21 31 889 899 I-clinical_variable
rate 32 36 900 904 I-clinical_variable
< 37 38 905 906 O
60mg 38 42 906 910 B-upper_bound
/ 42 43 910 911 I-upper_bound
dl 43 45 911 913 I-upper_bound

Hemoglobin 0 10 914 924 B-clinical_variable
< 11 12 925 926 O
10mg 12 16 926 930 B-upper_bound
/ 16 17 930 931 I-upper_bound
dL 17 19 931 933 I-upper_bound

Hemophilia 0 10 934 944 B-chronic_disease

History 0 7 945 952 O
of 8 10 953 955 O
having 11 17 956 962 O
undergone 18 27 963 972 O
gastrostomy 28 39 973 984 B-treatment
at 40 42 985 987 O
the 43 46 988 991 O
time 47 51 992 996 O
of 52 54 997 999 O
screening 55 64 1000 1009 O

History 0 7 1010 1017 O
of 8 10 1018 1020 O
positive 11 19 1021 1029 O
test 20 24 1030 1034 O
or 25 27 1035 1037 O
positive 28 36 1038 1046 O
result 37 43 1047 1053 O
at 44 46 1054 1056 O
screening 47 56 1057 1066 O
for 57 60 1067 1070 O
HIV 61 64 1071 1074 B-chronic_disease
or 65 67 1075 1077 O
HTLV-1 68 74 1078 1084 B-chronic_disease

If 0 2 1085 1087 O
taking 3 9 1088 1094 O
riluzole 10 18 1095 1103 B-treatment
or 19 21 1104 1106 O
edaravone 22 31 1107 1116 B-treatment
, 31 32 1116 1117 O
must 33 37 1118 1122 O
be 38 40 1123 1125 O
on 41 43 1126 1128 O
a 44 45 1129 1130 O
stable 46 52 1131 1137 O
dose 53 57 1138 1142 O
for 58 61 1143 1146 O
at 62 64 1147 1149 O
least 65 70 1150 1155 O
30 71 73 1156 1158 B-lower_bound
days 74 78 1159 1163 I-lower_bound
prior 79 84 1164 1169 I-lower_bound
to 85 87 1170 1172 O
the 88 91 1173 1176 O
screening 92 101 1177 1186 O
visit 102 107 1187 1192 O
, 107 108 1192 1193 O
or 109 111 1194 1196 O
stopped 112 119 1197 1204 O
taking 120 126 1205 1211 O
riluzole 127 135 1212 1220 O
or 136 138 1221 1223 O
edaravone 139 148 1224 1233 O
at 149 151 1234 1236 O
least 152 157 1237 1242 O
30 158 160 1243 1245 O
days 161 165 1246 1250 O
prior 166 171 1251 1256 O
to 172 174 1257 1259 O
the 175 178 1260 1263 O
screening 179 188 1264 1273 O
visit 189 194 1274 1279 O

Known 0 5 1280 1285 O
sulfonamide 6 17 1286 1297 B-allergy_name
allergy 18 25 1298 1305 O

PT 0 2 1306 1308 B-clinical_variable
and 3 6 1309 1312 O
PTT 7 10 1313 1316 B-clinical_variable
> 11 12 1317 1318 O
1.2 12 15 1318 1321 B-lower_bound
times 16 21 1322 1327 I-lower_bound
the 22 25 1328 1331 I-lower_bound
upper 26 31 1332 1337 I-lower_bound
limit 32 37 1338 1343 I-lower_bound
of 38 40 1344 1346 I-lower_bound
normal 41 47 1347 1353 I-lower_bound
for 48 51 1354 1357 O
the 52 55 1358 1361 O
NIH 56 59 1362 1365 O
Clinical 60 68 1366 1374 O
Center 69 75 1375 1381 O

Participation 0 13 1382 1395 O
in 14 16 1396 1398 O
any 17 20 1399 1402 O
other 21 26 1403 1408 B-treatment
investigational 27 42 1409 1424 I-treatment
drug 43 47 1425 1429 I-treatment
trial 48 53 1430 1435 I-treatment
or 54 56 1436 1438 O
using 57 62 1439 1444 O
investigational 63 78 1445 1460 O
drug 79 83 1461 1465 O
( 84 85 1466 1467 O
within 85 91 1467 1473 O
12 92 94 1474 1476 B-upper_bound
weeks 95 100 1477 1482 I-upper_bound
prior 101 106 1483 1488 I-upper_bound
to 107 109 1489 1491 O
Screening 110 119 1492 1501 O
and 120 123 1502 1505 O
thereafter 124 134 1506 1516 O
) 134 135 1516 1517 O

Platelet 0 8 1518 1526 B-clinical_variable
concentration 9 22 1527 1540 I-clinical_variable
of 23 25 1541 1543 O
< 26 27 1544 1545 O
100,000/ 27 35 1545 1553 B-upper_bound
( 36 37 1554 1555 I-upper_bound
micro)l 37 44 1555 1562 I-upper_bound

Positive 0 8 1563 1571 O
Hepatitis 9 18 1572 1581 B-chronic_disease
B 19 20 1582 1583 I-chronic_disease
Surface 21 28 1584 1591 O
Antigen 29 36 1592 1599 O
and 37 40 1600 1603 O
Hepatitis 41 50 1604 1613 B-chronic_disease
C 51 52 1614 1615 I-chronic_disease
Virus 53 58 1616 1621 O
Antibody 59 67 1622 1630 O

Serum 0 5 1631 1636 B-clinical_variable
creatinine 6 16 1637 1647 I-clinical_variable
, 16 17 1647 1648 O
serum 18 23 1649 1654 B-clinical_variable
phosphorous 24 35 1655 1666 I-clinical_variable
, 35 36 1666 1667 O
urine 37 42 1668 1673 B-clinical_variable
glucose 43 50 1674 1681 I-clinical_variable
, 50 51 1681 1682 O
urine 52 57 1683 1688 B-clinical_variable
protein 58 65 1689 1696 I-clinical_variable
, 65 66 1696 1697 O
total 67 72 1698 1703 B-clinical_variable
bilirubin 73 82 1704 1713 I-clinical_variable
, 82 83 1713 1714 O
triglycerides 84 97 1715 1728 B-clinical_variable
, 97 98 1728 1729 O
amylase 99 106 1730 1737 B-clinical_variable
, 106 107 1737 1738 O
or 108 110 1739 1741 O
lipase 111 117 1742 1748 B-clinical_variable
greater 118 125 1749 1756 O
than 126 130 1757 1761 O
2.0 131 134 1762 1765 B-lower_bound
times 135 140 1766 1771 I-lower_bound
the 141 144 1772 1775 I-lower_bound
upper 145 150 1776 1781 I-lower_bound
limit 151 156 1782 1787 I-lower_bound
of 157 159 1788 1790 I-lower_bound
normal 160 166 1791 1797 I-lower_bound
for 167 170 1798 1801 O
the 171 174 1802 1805 O
NIH 175 178 1806 1809 O
Clinical 179 187 1810 1818 O
Center 188 194 1819 1825 O

Time 0 4 1826 1830 B-clinical_variable
from 5 9 1831 1835 I-clinical_variable
symptom 10 17 1836 1843 I-clinical_variable
onset 18 23 1844 1849 I-clinical_variable
less 24 28 1850 1854 O
than 29 33 1855 1859 O
2 34 35 1860 1861 B-upper_bound
years 36 41 1862 1867 I-upper_bound

Unstable 0 8 1868 1876 O
medical 9 16 1877 1884 B-chronic_disease
disease 17 24 1885 1892 I-chronic_disease
( 25 26 1893 1894 O
such 26 30 1894 1898 O
as 31 33 1899 1901 O
unstable 34 42 1902 1910 B-chronic_disease
angina 43 49 1911 1917 I-chronic_disease
or 50 52 1918 1920 O
chronic 53 60 1921 1928 B-chronic_disease
obstructive 61 72 1929 1940 I-chronic_disease
pulmonary 73 82 1941 1950 I-chronic_disease
disease 83 90 1951 1958 I-chronic_disease
) 90 91 1958 1959 O
, 91 92 1959 1960 O
or 93 95 1961 1963 O
active 96 102 1964 1970 B-chronic_disease
infectious 103 113 1971 1981 I-chronic_disease
disease 114 121 1982 1989 I-chronic_disease
( 122 123 1990 1991 O
such 123 127 1991 1995 O
as 128 130 1996 1998 O
Hepatitis 131 140 1999 2008 B-chronic_disease
C 141 142 2009 2010 I-chronic_disease
or 143 145 2011 2013 O
tuberculosis 146 158 2014 2026 B-chronic_disease
) 158 159 2026 2027 O
, 159 160 2027 2028 O
or 161 163 2029 2031 O
current 164 171 2032 2039 O
malignancy 172 182 2040 2050 B-cancer

Unstable 0 8 2051 2059 O
psychiatric 9 20 2060 2071 B-chronic_disease
illness 21 28 2072 2079 I-chronic_disease
defined 29 36 2080 2087 O
as 37 39 2088 2090 O
psychosis 40 49 2091 2100 B-chronic_disease
or 50 52 2101 2103 O
untreated 53 62 2104 2113 O
major 63 68 2114 2119 B-chronic_disease
depression 69 79 2120 2130 I-chronic_disease
within 80 86 2131 2137 O
90 87 89 2138 2140 B-upper_bound
days 90 94 2141 2145 I-upper_bound
of 95 97 2146 2148 O
the 98 101 2149 2152 O
screening 102 111 2153 2162 O
visit 112 117 2163 2168 O

Use 0 3 2169 2172 O
of 4 6 2173 2175 O
contraindicated 7 22 2176 2191 O
medications 23 34 2192 2203 O
: 34 35 2203 2204 O
amiodarone 36 46 2205 2215 B-treatment
, 46 47 2215 2216 O
dronedarone 48 59 2217 2228 B-treatment
, 59 60 2228 2229 O
lovastatin 61 71 2230 2240 B-treatment
, 71 72 2240 2241 O
simvastatin 73 84 2242 2253 B-treatment
, 84 85 2253 2254 O
rifampin 86 94 2255 2263 B-treatment
, 94 95 2263 2264 O
rifapentine 96 107 2265 2276 B-treatment
, 107 108 2276 2277 O
rifabutin 109 118 2278 2287 B-treatment
, 118 119 2287 2288 O
cisapride 120 129 2289 2298 B-treatment
, 129 130 2298 2299 O
pimozide 131 139 2300 2308 B-treatment
, 139 140 2308 2309 O
midazolam 141 150 2310 2319 B-treatment
, 150 151 2319 2320 O
triazolam 152 161 2321 2330 B-treatment
, 161 162 2330 2331 O
dihydroergotamine 163 180 2332 2349 B-treatment
, 180 181 2349 2350 O
ergonovine 182 192 2351 2361 B-treatment
, 192 193 2361 2362 O
ergotamine 194 204 2363 2373 O
, 204 205 2373 2374 O
methylergonovine 206 222 2375 2391 B-treatment
, 222 223 2391 2392 O
St. 224 227 2393 2396 B-treatment
John 228 232 2397 2401 I-treatment
s 233 234 2402 2403 I-treatment
wort 235 239 2404 2408 I-treatment
, 239 240 2408 2409 O
alfuzosin 241 250 2410 2419 B-treatment
, 250 251 2419 2420 O
salmeterol 252 262 2421 2431 B-treatment
, 262 263 2431 2432 O
sildenafil 264 274 2433 2443 B-treatment
for 275 278 2444 2447 O
pulmonary 279 288 2448 2457 B-chronic_disease
arterial 289 297 2458 2466 I-chronic_disease
hypertension 298 310 2467 2479 I-chronic_disease
, 310 311 2479 2480 O
oxcarbazepine 312 325 2481 2494 B-treatment
, 325 326 2494 2495 O
phenobarbital 327 340 2496 2509 B-treatment
, 340 341 2509 2510 O
phenytoin 342 351 2511 2520 B-treatment
or 352 354 2521 2523 O
dofetilide 355 365 2524 2534 B-treatment

competent 0 9 2535 2544 O
caregiver 10 19 2545 2554 O
who 20 23 2555 2558 O
can 24 27 2559 2562 O
and 28 31 2563 2566 O
will 32 36 2567 2571 O
be 37 39 2572 2574 O
responsible 40 51 2575 2586 O
for 52 55 2587 2590 O
administering 56 69 2591 2604 O
study 70 75 2605 2610 B-treatment
drug 76 80 2611 2615 I-treatment

had 0 3 2616 2619 O
neuroimaging 4 16 2620 2632 B-treatment
within 17 23 2633 2639 O
the 24 27 2640 2643 O
last 28 32 2644 2648 B-upper_bound
18 33 35 2649 2651 I-upper_bound
months 36 42 2652 2658 I-upper_bound

hildbearing 0 11 2659 2670 O
potential 12 21 2671 2680 O
must 22 26 2681 2685 O
have 27 31 2686 2690 O
a 32 33 2691 2692 O
negative 34 42 2693 2701 B-pregnancy
pregnancy 43 52 2702 2711 I-pregnancy
test 53 57 2712 2716 O
at 58 60 2717 2719 O
screening 61 70 2720 2729 O
and 71 74 2730 2733 O
be 75 77 2734 2736 O
non 78 81 2737 2740 O
- 81 82 2740 2741 O
lactating 82 91 2741 2750 O

must 0 4 2751 2755 O
not 5 8 2756 2759 B-pregnancy
be 9 11 2760 2762 I-pregnancy
able 12 16 2763 2767 I-pregnancy
to 17 19 2768 2770 I-pregnancy
become 20 26 2771 2777 I-pregnancy
pregnant 27 35 2778 2786 I-pregnancy
( 36 37 2787 2788 O
e.g. 37 41 2788 2792 O
, 41 42 2792 2793 O
post 43 47 2794 2798 O
- 47 48 2798 2799 O
menopausal 48 58 2799 2809 O
for 59 62 2810 2813 O
at 63 65 2814 2816 O
least 66 71 2817 2822 O
one 72 75 2823 2826 B-lower_bound
year 76 80 2827 2831 I-lower_bound
, 80 81 2831 2832 O
surgically 82 92 2833 2843 O
sterile 93 100 2844 2851 O
, 100 101 2851 2852 O
or 102 104 2853 2855 O
using 105 110 2856 2861 B-contraception_consent
adequate 111 119 2862 2870 I-contraception_consent
methods 120 127 2871 2878 I-contraception_consent
of 128 130 2879 2881 I-contraception_consent
contraception 131 144 2882 2895 I-contraception_consent
) 144 145 2895 2896 O
or 146 148 2897 2899 O
breastfeed 149 159 2900 2910 O
for 160 163 2911 2914 O
the 164 167 2915 2918 O
duration 168 176 2919 2927 O
of 177 179 2928 2930 O
the 180 183 2931 2934 O
study 184 189 2935 2940 O
. 189 190 2940 2941 O
Adequate 191 199 2942 2950 O
methods 200 207 2951 2958 O
of 208 210 2959 2961 O
contraception 211 224 2962 2975 O
include 225 232 2976 2983 O
: 232 233 2983 2984 O
implanted 234 243 2985 2994 O
contraception 244 257 2995 3008 O
, 257 258 3008 3009 O
intrauterine 259 271 3010 3022 O
device 272 278 3023 3029 O
in 279 281 3030 3032 O
place 282 287 3033 3038 O
for 288 291 3039 3042 O
at 292 294 3043 3045 O
least 295 300 3046 3051 O
3 301 302 3052 3053 B-lower_bound
months 303 309 3054 3060 I-lower_bound
, 309 310 3060 3061 O
or 311 313 3062 3064 O
barrier 314 321 3065 3072 O
method 322 328 3073 3079 O
in 329 331 3080 3082 O
conjunction 332 343 3083 3094 O
with 344 348 3095 3099 O
spermicide 349 359 3100 3110 O

